These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience. Buonuomo PS; Macchiaiolo M; Leone G; Valente P; Mastrogiorgio G; Gnazzo M; Rana I; Gonfiantini MV; Gagliardi MG; Romano F; Bartuli A Eur J Prev Cardiol; 2018 Jul; 25(10):1098-1105. PubMed ID: 29785886 [TBL] [Abstract][Full Text] [Related]
3. Homozygous familial hypercholesterolaemia and treatment by LDL apheresis. King RI; Scott RS; Florkowski CM; Laurie AD; Reid N; George PM N Z Med J; 2010 Jul; 123(1319):79-82. PubMed ID: 20717180 [No Abstract] [Full Text] [Related]
7. Managing homozygous familial hypercholesterolaemia from cradle to grave. Thompson GR Atheroscler Suppl; 2015 May; 18():16-20. PubMed ID: 25936299 [TBL] [Abstract][Full Text] [Related]
8. Homozygous familial hypercholesterolaemia: development of xanthogranuloma in a boy at puberty under long-term low-density lipoprotein apheresis and drug therapy. Saito M; Tada Y; Harada-Shiba M; Yamamoto A; Kusakabe N; Yokogawa M; Kodama H; Asada H; Miyagawa S Br J Dermatol; 2003 Dec; 149(6):1302-3. PubMed ID: 14674920 [No Abstract] [Full Text] [Related]
9. Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France. Bruckert E; Kalmykova O; Bittar R; Carreau V; Béliard S; Saheb S; Rosenbaum D; Bonnefont-Rousselot D; Thomas D; Emery C; Khoshnood B; Carrié A Atherosclerosis; 2017 Feb; 257():130-137. PubMed ID: 28131047 [TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia. Meier P; Blanc E Nephrol Dial Transplant; 2000 May; 15(5):738-40. PubMed ID: 10809830 [No Abstract] [Full Text] [Related]
11. [Genetic principles of food related problems--familial hypercholesterolaemia]. Floré M; Robberecht N; Hermans H J Pharm Belg; 2012 Mar; (1):18-21. PubMed ID: 22536679 [No Abstract] [Full Text] [Related]
12. Current concepts in the treatment of familial hypercholesterolaemia. Packard CJ; Shepherd J Curr Opin Lipidol; 1995 Feb; 6(1):57-61. PubMed ID: 7735717 [TBL] [Abstract][Full Text] [Related]
13. Recommendations for the management of patients with homozygous familial hypercholesterolaemia: overview of a new European Atherosclerosis Society consensus statement. Bruckert E Atheroscler Suppl; 2014 Sep; 15(2):26-32. PubMed ID: 25257074 [TBL] [Abstract][Full Text] [Related]
14. [Homozygous familial hypercholesterolaemia: Spanish adaptation of the position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Consensus document of the Spanish Society of Arteriosclerosis (SEA) and Familial Hypercholesterolaemia Foundation (FHF)]. Ascaso JF; Mata P; Arbona C; Civeira F; Valdivielso P; Masana L Clin Investig Arterioscler; 2015; 27(2):80-96. PubMed ID: 25757840 [TBL] [Abstract][Full Text] [Related]
15. Severe familial hypercholesterolaemia: current and future management. Farnier M; Bruckert E Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621 [TBL] [Abstract][Full Text] [Related]
16. Guidelines for the diagnosis and management of familial hypercholesterolaemia. Sullivan D; Heart Lung Circ; 2007 Feb; 16(1):25-7. PubMed ID: 17188936 [No Abstract] [Full Text] [Related]
17. Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study. Raal FJ; Hovingh GK; Blom D; Santos RD; Harada-Shiba M; Bruckert E; Couture P; Soran H; Watts GF; Kurtz C; Honarpour N; Tang L; Kasichayanula S; Wasserman SM; Stein EA Lancet Diabetes Endocrinol; 2017 Apr; 5(4):280-290. PubMed ID: 28215937 [TBL] [Abstract][Full Text] [Related]
18. Images in clinical medicine. Homozygous familial hypercholesterolemia. Genest J; Lavoie MA N Engl J Med; 1999 Aug; 341(7):490. PubMed ID: 10441605 [No Abstract] [Full Text] [Related]
19. Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia. Kolovou G; Diakoumakou O; Kolovou V; Fountas E; Stratakis S; Zacharis E; Liberopoulos EN; Matsouka F; Tsoutsinos A; Mastorakou I; Katsikas T; Mavrogeni S; Hatzigeorgiou G Eur J Prev Cardiol; 2020 Jan; 27(2):157-165. PubMed ID: 31403880 [TBL] [Abstract][Full Text] [Related]